Elżbieta Ber

Structural Optimization Affording 2-(<i>R</i>)-(1-(<i>R</i>)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(<i>S</i>)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss et al. · Journal of Medicinal Chemistry · 1998 · 203 citations · Full text

Orally Active, Pharmacotherapy, Pharmaceutical Chemistry +21

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

N.M.J. Rupniak, F.D. Tattersall, Angela Williams et al. · European Journal of Pharmacology · 1997 · 117 citations

Medicine, Receptor Tyrosine Kinase, Immunology +8

Phosphorylated Morpholine Acetal Human Neurokinin-1 Receptor Antagonists as Water-Soluble Prodrugs

Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss et al. · Journal of Medicinal Chemistry · 2000 · 95 citations · Full text

Regioselective Dibenzylphosphorylation, Biochemistry, Medicine +14

Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor

Margaret A. Cascieri, Gregory Koch, Elżbieta Ber et al. · Journal of Biological Chemistry · 1999 · 92 citations · Full text

N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists

Angus M. MacLeod, Kevin J. Merchant, Margaret A. Cascieri et al. · Journal of Medicinal Chemistry · 1993 · 71 citations · Full text

Pharmaceutical Science, Altmetric Attention Score, Pharmacotherapy +18